These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 641812)

  • 21. Strand scission of DNA by bound adriamycin and daunorubicin in the presence of reducing agents.
    Lown JW; Sim SK; Majumdar KC; Chang RY
    Biochem Biophys Res Commun; 1977 Jun; 76(3):705-10. PubMed ID: 197922
    [No Abstract]   [Full Text] [Related]  

  • 22. Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia.
    Inaba M; Johnson RK
    Biochem Pharmacol; 1978; 27(17):2123-30. PubMed ID: 31880
    [No Abstract]   [Full Text] [Related]  

  • 23. Thiol-dependent DNA damage produced by anthracycline-iron complexes. The structure-activity relationships and molecular mechanisms.
    Muindi J; Sinha BK; Gianni L; Myers C
    Mol Pharmacol; 1985 Mar; 27(3):356-65. PubMed ID: 2983184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-association of daunorubicin.
    Barthelemy-Clavey V; Maurizot JC; Dimicoli JL; Sicard P
    FEBS Lett; 1974 Sep; 46(1):5-10. PubMed ID: 4417418
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of anthracycline--DNA complexes by circular dichroism.
    Rizzo V; Penco S; Menozzi M; Geroni C; Vigevani A; Arcamone F
    Anticancer Drug Des; 1988 Aug; 3(2):103-15. PubMed ID: 3165639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport and storage of daunorubicin and doxorubicin in cultured fibroblasts.
    Peterson C; Trouet A
    Cancer Res; 1978 Dec; 38(12):4645-9. PubMed ID: 719643
    [No Abstract]   [Full Text] [Related]  

  • 28. Biodistribution of intravenously injected [14C] doxorubicin and [14C] daunorubicin in mice: concise communication.
    Harrison K; Wagner NH
    J Nucl Med; 1978 Jan; 19(1):84-6. PubMed ID: 621570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.
    Noel G; Peterson C; Trouet A; Tulkens P
    Eur J Cancer (1965); 1978 Apr; 14(4):363-8. PubMed ID: 648557
    [No Abstract]   [Full Text] [Related]  

  • 30. GLC--mass spectrometry of several important anticancer drugs II: doxorubicin and daunorubicin aglycone analogs.
    Chan KK; Watson E
    J Pharm Sci; 1978 Dec; 67(12):1748-52. PubMed ID: 722494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in Ehrlich ascites tumour cells.
    Skovsgaard T
    Biochem Pharmacol; 1978; 27(8):1221-7. PubMed ID: 567991
    [No Abstract]   [Full Text] [Related]  

  • 32. Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells.
    Fiallo M; Laigle A; Borrel MN; Garnier-Suillerot A
    Biochem Pharmacol; 1993 Feb; 45(3):659-65. PubMed ID: 8095138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proceedings: Daunomycin and adriamycin antitumor cell antibody conjugates.
    Hurwitz E; Levy R; Maron R
    Isr J Med Sci; 1975 Dec; 11(12):1396. PubMed ID: 1218993
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of the stability of doxorubicin and daunorubicin in solid state.
    Cielecka-Piontek J; Jelińska A; Zajac M; Sobczak M; Bartold A; Oszczapowicz I
    J Pharm Biomed Anal; 2009 Nov; 50(4):576-9. PubMed ID: 19195811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of daunomycin to diaminopurine- and/or inosine-substituted DNA.
    Bailly C; Suh D; Waring MJ; Chaires JB
    Biochemistry; 1998 Jan; 37(4):1033-45. PubMed ID: 9454594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The discovery of daunorubicin.
    Di Marco A; Cassinelli G; Arcamone F
    Cancer Treat Rep; 1981; 65 Suppl 4():3-8. PubMed ID: 7049379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytofluorescence localization of adriamycin and daunorubicin.
    Egorin MJ; Hildebrand RC; Cimino EF; Bachur NR
    Cancer Res; 1974 Sep; 34(9):2243-5. PubMed ID: 4843531
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of intracellular drug retention, DNA damage and cytotoxicity of derivatives of doxorubicin and daunorubicin in a human colon adenocarcinoma cell line (LoVo).
    Belvedere G; Suarato A; Geroni C; Giuliani FC; D'Incalci M
    Biochem Pharmacol; 1989 Nov; 38(21):3713-21. PubMed ID: 2557027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A differential interaction of doxorubicin and daunorubicin with human serum proteins.
    Zunino F; Gambetta RA; Zaccara A; Carsana R
    Tumori; 1981 Oct; 67(5):399-403. PubMed ID: 7324172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermodynamic characterization of daunomycin-DNA interactions: comparison of complete binding profiles for a series of DNA host duplexes.
    Remeta DP; Mudd CP; Berger RL; Breslauer KJ
    Biochemistry; 1993 May; 32(19):5064-73. PubMed ID: 8494883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.